(Q33831980)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Recommendations for the use of botulinum toxin type A in the management of cerebral palsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

main subject

botulinum toxin type A

1 reference

inferred from title

author

Deborah Gaebler-Spira

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Mark E. Gormley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Pedro J Garcia Ruiz

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

15

Wissel J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Graham HK

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Aoki KR

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Autti-Rämö I

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Boyd RN

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Delgado MR

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Guyer BM

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Heinen F

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Holton AF

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Matthews D

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Molenaers G

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Motta F

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

number of pages

13

1 reference

inferred from page(s)

published in

Gait and Posture

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

67-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation?

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Molecular aspects of tetanus and botulinum neurotoxin poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Dose standardisation of botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Botulinum A toxins: units versus units

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Botulinum toxin A in the hemiplegic upper limb: a double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Botulinum toxin in the management of the lower limb in cerebral palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

125I-Labelled botulinum a neurotoxin: Pharmacokinetics in cats after intramuscular injection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Local tetanus in cats: neuropharmacokinetics of 125 I-tetanus toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Local tetanus in cats: the influence of neuromuscular activity on spinal distribution of 125 I labelled tetanus toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Transient urinary incontinence after botulinum A toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Absence of antibody production in patients treated with botulinum A toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Negative antibody response to long-term treatment of facial spasm with botulinum toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Development of resistance to botulinum toxin type A in patients with torticollis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Antibodies to botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Interventional neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Dystonic posture of lower extremities associated with myelomeningocele: successful treatment with botulinum A toxin in a six-month-old child

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

The gross motor function measure: a means to evaluate the effects of physical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Interrater reliability of a modified Ashworth scale of muscle spasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

A Developmental Prehension Assessment for Handicapped Children

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Botulinum toxin A in hamstring spasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0966-6362%2899%2900054-5

7 January 2021

10.1016/S0966-6362(99)00054-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10664488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference